Interestingly, the contribution of Plasma cells is associated with response to Nivolumab, and we observed an increasing trend of the Naïve B-cell population in good responders.
← all excerpts
High IGKC-Expressing Intratumoral Plasma Cells Predict Response to Immune Checkpoint Blockade.
1
—
—